Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Internet Usage by Polish Patients With Multiple Sclerosis: A Multicenter Questionnaire Study.

Potemkowski A, Brola W, Ratajczak A, Ratajczak M, Zaborski J, Jasińska E, Pokryszko-Dragan A, Gruszka E, Dubik-Jezierzańska M, Podlecka-Piętowska A, Nojszewska M, Gospodarczyk-Szot K, Stępień A, Gocyła-Dudar K, Maciągowska-Terela M, Wencel J, Kaźmierski R, Kułakowska A, Kapica-Topczewska K, Pawełczak W, Bartosik-Psujek H.

Interact J Med Res. 2019 Feb 1;8(1):e11146. doi: 10.2196/11146.

2.

Apparent diffusion coefficient measurements in normal appearing white matter may support the differential diagnosis between multiple sclerosis lesions and other white matter hyperintensities.

Zacharzewska-Gondek A, Pokryszko-Dragan A, Gondek TM, Kołtowska A, Gruszka E, Budrewicz S, Sąsiadek M, Bladowska J.

J Neurol Sci. 2019 Feb 15;397:24-30. doi: 10.1016/j.jns.2018.12.018. Epub 2018 Dec 14.

PMID:
30580051
3.

Diffusion tensor imaging findings in the multiple sclerosis patients and their relationships to various aspects of disability.

Pokryszko-Dragan A, Banaszek A, Nowakowska-Kotas M, Jeżowska-Jurczyk K, Dziadkowiak E, Gruszka E, Zagrajek M, Bilińska M, Budrewicz S, Sąsiadek M, Bladowska J.

J Neurol Sci. 2018 Aug 15;391:127-133. doi: 10.1016/j.jns.2018.06.007. Epub 2018 Jun 13.

PMID:
30103962
4.

Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.

Szmyrka M, Pokryszko-Dragan A, Słotwiński K, Gruszka E, Korman L, Podemski R, Wiland P.

Adv Clin Exp Med. 2019 Feb;28(2):185-192. doi: 10.17219/acem/76711.

5.

The relationship between epileptiform discharges and background activity in the visual analysis of electroencephalographic examinations in dogs with seizures of different etiologies.

Wrzosek M, Ives JR, Karczewski M, Dziadkowiak E, Gruszka E.

Vet J. 2017 Apr;222:41-51. doi: 10.1016/j.tvjl.2017.03.003. Epub 2017 Mar 16.

PMID:
28410675
6.

Cognitive performance, fatigue and event-related potentials in patients with clinically isolated syndrome.

Pokryszko-Dragan A, Dziadkowiak E, Zagrajek M, Slotwinski K, Gruszka E, Bilinska M, Podemski R.

Clin Neurol Neurosurg. 2016 Oct;149:68-74. doi: 10.1016/j.clineuro.2016.07.022. Epub 2016 Jul 15.

PMID:
27484631
7.

Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue.

Pokryszko-Dragan A, Zagrajek M, Slotwinski K, Bilinska M, Gruszka E, Podemski R.

Neurol Sci. 2016 Sep;37(9):1545-56. doi: 10.1007/s10072-016-2622-x. Epub 2016 Jun 6.

8.

Assessment of visual and auditory evoked potentials in multiple sclerosis patients with and without fatigue.

Pokryszko-Dragan A, Bilinska M, Gruszka E, Kusinska E, Podemski R.

Neurol Sci. 2015 Feb;36(2):235-42. doi: 10.1007/s10072-014-1953-8. Epub 2014 Sep 21.

9.

Magnetic resonance spectroscopy findings as related to fatigue and cognitive performance in multiple sclerosis patients with mild disability.

Pokryszko-Dragan A, Bladowska J, Zimny A, Slotwinski K, Zagrajek M, Gruszka E, Bilinska M, Sasiadek M, Podemski R.

J Neurol Sci. 2014 Apr 15;339(1-2):35-40. doi: 10.1016/j.jns.2014.01.013. Epub 2014 Jan 15.

PMID:
24468541
10.

In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging.

Zimny A, Szmyrka-Kaczmarek M, Szewczyk P, Bladowska J, Pokryszko-Dragan A, Gruszka E, Wiland P, Sasiadek M.

Lupus. 2014;23(1):10-9. doi: 10.1177/0961203313511556. Epub 2013 Nov 5.

PMID:
24192079
11.

Dynamics of magnetic resonance image changes in a patient with Creutzfeldt-Jakob disease.

Kowalczyk E, Szewczyk P, Budrewicz S, Koszewicz M, Gruszka E, Slotwinski K, Podemski R.

Eur Neurol. 2013;70(3-4):139-40. doi: 10.1159/000352038. Epub 2013 Jul 25. No abstract available.

PMID:
23886950
12.

Sleep disturbances in patients with multiple sclerosis.

Pokryszko-Dragan A, Bilińska M, Gruszka E, Biel Ł, Kamińska K, Konieczna K.

Neurol Sci. 2013 Aug;34(8):1291-6. doi: 10.1007/s10072-012-1229-0. Epub 2012 Oct 30.

13.

Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis.

Pokryszko-Dragan A, Frydecka I, Kosmaczewska A, Ciszak L, Bilińska M, Gruszka E, Podemski R, Frydecka D.

Clin Neurol Neurosurg. 2012 Oct;114(8):1153-8. doi: 10.1016/j.clineuro.2012.02.048. Epub 2012 Mar 16.

PMID:
22425464
14.

Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.

Szmyrka-Kaczmarek M, Pokryszko-Dragan A, Pawlik B, Gruszka E, Korman L, Podemski R, Wiland P, Szechinski J.

Lupus. 2012 Apr;21(4):412-20. doi: 10.1177/0961203311427550. Epub 2011 Nov 10.

PMID:
22074845
15.

Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.

Pokryszko-Dragan A, Zagrajek M, Slotwinski K, Gruszka E, Bilinska M, Podemski R.

Clin Neurol Neurosurg. 2009 Jul;111(6):503-6. doi: 10.1016/j.clineuro.2009.01.009. Epub 2009 Feb 23.

PMID:
19233546
16.

Secondary progressive multiple sclerosis - clinical course and potential predictive factors.

Pokryszko-Dragan A, Gruszka E, Bilińska M, Dubik-Jezierzańska M.

Neurol Neurochir Pol. 2008 Jan-Feb;42(1):6-11.

PMID:
18365957
17.

[Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].

Pokryszko-Dragan A, Bilińska M, Gruszka E, Dubik-Jezierzańska M.

Pol Merkur Lekarski. 2005 Nov;19(113):654-8. Polish.

PMID:
16498805
18.

Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.

Boćko D, Bilińska M, Dobosz T, Zołedziewska M, Suwalska K, Tutak A, Gruszka E, Frydecka I.

Arch Immunol Ther Exp (Warsz). 2003;51(3):201-5.

PMID:
12894875
19.

Fas expression on T cells and sFas in relapsing-remitting multiple sclerosis.

Bilinska M, Frydecka I, Podemski R, Gruszka E.

Acta Neurol Scand. 2003 Jun;107(6):387-93.

PMID:
12757469
20.

Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.

Bilińska M, Frydecka I, Podemski R, Gruszka E.

Med Sci Monit. 2002 Oct;8(10):CR720-3.

PMID:
12388926

Supplemental Content

Loading ...
Support Center